Caribou Biosciences Company
Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.
Investors
Last Funding Type:
Series C
Funding Status:
Late Stage Venture
Headquarters:
Berkeley, California, United States
Founded Date:
2011
Investor Type:
Late Stage Venture
Investment Stage:
N/A
Last Funding Date:
2021
Total Funding:
167549904
Technology:
Others
Employee Number:
101-250
Number Of Exists:
1
Estimated Revenue:
$10M to $50M
Investors Number:
28
Industry:
Biotechnology, Health Care, Therapeutics